shortagewatch

Home / Companies / Cheplapharm

Company family · HQ DE

Cheplapharm: medicine shortages

private

As of 2 Nov 2026, 86 Cheplapharm products have a reported shortage across 12 countries, covering 28 medicines.

Products short86rank #21 of 464
Medicines28active ingredients
Countries12/16
New in 90 days28+11 vs market pace
Typical duration8 monthsmedian so far
Manufacturing47%demand-driven 36%

Where

United States3Canada6Germany13Italy9Spain4Ireland9Austria6Belgium10Switzerland1Czechia6Norway14Sweden5

Which therapeutic classes

Nervous system38Cardiovascular system15Cancer and immune system12Sensory organs9Blood4Dermatologicals3Digestive tract and metabolism3Antiparasitics2

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
CheplapharmCheplapharm: Manufacturing problem 35 (41%)41%Cheplapharm: Increased demand 27 (31%)31%Cheplapharm: Active ingredient shortage 2 (2%)Cheplapharm: Distribution or logistics 2 (2%)Cheplapharm: Commercial decision or withdrawal 3 (3%)Cheplapharm: Other 5 (6%)6%Cheplapharm: Not stated 12 (14%)14%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes
DateCountryMedicineChange
2 NovDEQuetiapine
Seroquel Prolong 150 mg Retardtabletten		resolved
2 NovDEQuetiapine
Seroquel Prolong 200 mg Retardtabletten		resolved
2 NovATOlanzapine
ZYPADHERA 210 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension		new shortage (back 16 Dec)
2 NovDEQuetiapine
Seroquel Prolong 200 mg Retardtabletten		new shortage (back 12 Feb)
2 NovDEQuetiapine
Seroquel Prolong 150 mg Retardtabletten		new shortage (back 30 Nov)
2 NovDEQuetiapine
Seroquel Prolong 400 mg Retardtabletten		new shortage (back 15 Jan)

Open shortages over time

3536383931 Oct2026-10-31: 361 Nov2026-11-01: 362 Nov2026-11-02: 38

Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.

When its current shortages began

05101520Dec: 0Jan ’25: 3Feb: 1FebMar: 2Apr: 0May: 3MayJun: 0Jul: 0Aug: 0AugSep: 4Oct: 1Nov: 2NovDec: 1Jan ’26: 0Feb: 6FebMar: 7Apr: 3May: 2MayJun: 5Jul: 2Aug: 2AugSep: 15Oct: 10Nov: 1Nov

Long-run trend in Canada

Canada dashboard
051015202020: 2220202021: 5520212022: 101020222023: 121220232024: 7720242025: 171720252026: 332026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Cheplapharm86

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Cheplapharm: 86 / 28Cheplapharm

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Quetiapine231 May 2025Increased demand12/16
Verteporfin922 Jun 2020Manufacturing problem10/16
Olanzapine818 Mar 2025Manufacturing problem13/16
Buserelin410 Aug 2023Manufacturing problem3/16
Candesartan36 Oct 2025Other10/16
Carvedilol310 Sep 2026Other8/16
Clonazepam310 Mar 2023Not stated4/16
Distigmine321 Mar 2024Active ingredient shortage2/16
Erlotinib31 Feb 2026Increased demand5/16
Candesartan and Diuretics26 Dec 2025Commercial decision or withdrawal5/16
Colestyramine211 Mar 2026Increased demand6/16
Erythromycin, Combinations23 Feb 2026Manufacturing problem1/16
Etoposide29 Apr 2026Manufacturing problem7/16
Mefloquine218 May 2026Increased demand3/16
Midodrine225 May 2026Increased demand2/16
Ticlopidine227 Mar 2026Manufacturing problem3/16
Capecitabine115 Oct 2026Increased demand6/16
Disopyramide124 Jan 2025Manufacturing problem3/16
Estazolam110 Oct 2026Manufacturing problem1/16
Glimepiride and Pioglitazone18 Sep 2026Not stated1/16
Hydroxycarbamide15 Oct 2026Other2/16
Nadolol123 Jun 2026Manufacturing problem1/16
Nilutamide118 Sep 2023Manufacturing problem2/16
Omeprazole122 Oct 2026Increased demand8/16
Phytomenadione112 Oct 2026Increased demand1/16
Pioglitazone110 Sep 2026Manufacturing problem7/16
Tranexamic Acid12 Sep 2026Manufacturing problem10/16
Urapidil17 Sep 2026Manufacturing problem4/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.